BSE Live
Dec 10, 16:01Prev. Close
190.10
Open Price
189.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 10, 15:52Prev. Close
190.11
Open Price
189.61
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
191.21 (20587)
| Cash Flow of Marksans Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 96.69 | 63.26 | 29.61 | -182.90 | -212.94 | |
| Net CashFlow From Operating Activities | 112.03 | 54.18 | 8.58 | -60.77 | -67.86 | |
| Net Cash Used In Investing Activities | -29.14 | -2.01 | -48.24 | 41.47 | 26.06 | |
| Net Cash Used From Financing Activities | 51.28 | -19.21 | 22.49 | 10.65 | 35.52 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 134.17 | 32.96 | -17.17 | -8.65 | -6.27 | |
| Cash And Cash Equivalents Begin of Year | 33.37 | 0.41 | 17.58 | 26.24 | 32.51 | |
| Cash And Cash Equivalents End Of Year | 167.54 | 33.37 | 0.41 | 17.58 | 26.24 |
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y